High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease

Summary

The purpose of this 4 week study is to determine whether PASER®, an approved delayed-release oral formulation of 4-aminosalicylic acid, in doses of 4 grams three times daily for 2 weeks followed by 4 grams twice daily for 2 weeks, will resolve an acute flare of ileocecal Crohn's disease.

Timeline

Start

2007-01

Primary completion

2007-12

Completion

2008-10

Outcome

Outcome not reported

Stopped (Enrollment): “Efforts at recruitment have halted as recruitment was poor.”

Drugs

Indications